Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
08/2012
08/16/2012WO2012107652A1 Effervescent gamma-hydroxybutyric acid granules
08/16/2012WO2012107648A1 Anti-inflammatory effect of microfibrillated cellulose
08/16/2012WO2012107602A1 Form of administration of phospholipids for the formation on the skin of laminar phospholipid layers
08/16/2012WO2012107585A1 Novel concentrated and stable topical antiparasitic compositions
08/16/2012WO2012107575A1 Novel formulations for dermal, transdermal and mucosal use 2
08/16/2012WO2012107573A1 Novel formulations for dermal, transdermal and mucosal use 3
08/16/2012WO2012107565A1 Novel antifungal composition
08/16/2012WO2012107564A1 Novel formulations for dermal, transdermal and mucosal use 1
08/16/2012WO2012107541A1 Pharmaceutical composition comprising tadalafil and a cyclodextrin
08/16/2012WO2012107493A1 Dual drug pen-injection device with micro-reservoirs carrying secondary drug for emergency injection
08/16/2012WO2012107364A1 Novel composition for the treatment of cystic fibrosis
08/16/2012WO2012107363A1 Novel composition for the treatment of cystic fibrosis
08/16/2012WO2012107356A1 Aqueous pharmaceutical composition for preventing and/or treating allergically irritated nasal mucosa and use thereof
08/16/2012WO2012107207A1 Sweetener and/or a sweetness enhancer, sweetener compositions, methods of making and using same, and consumables containing same
08/16/2012WO2012107202A1 Sweetener, sweetener compositions, methods of making the same and consumables containing the same
08/16/2012WO2012107093A1 Storage-stable formulation of paracetamol in aqueous solution
08/16/2012WO2012107092A1 Pharmaceutical composition comprising tadalafil and a cyclodextrin
08/16/2012WO2012107090A1 Granulated composition comprising tadalafil and a disintegrant
08/16/2012WO2012106751A1 Artificial oil bodies
08/16/2012WO2012087255A3 Pharmaceutical formulations comprising imatinib
08/16/2012WO2012087051A3 Microparticles containing physiologically active peptide, method for preparing the same, and pharmaceutical composition comprising the same
08/16/2012WO2012087047A3 Percutaneous absorption preparation containing rivastigmine
08/16/2012WO2012085043A3 Rapidly disintegrating, solid coated dosage form
08/16/2012WO2012084759A3 Instant powders for aqueous cosmetic and pharmaceutical applications
08/16/2012WO2012084754A3 Pharmaceutical glp-1 compositions having an improved release profile
08/16/2012WO2012080984A3 Controlled-release pharmaceutical tablet for oral administration
08/16/2012WO2012080466A3 Ingenols for treating seborrheic keratosis
08/16/2012WO2012079721A8 Terpenoid spiro ketal compounds with lxr agonists activity, their use and formulations with them
08/16/2012WO2012078667A9 Compositions and methods relating to proliferative diseases
08/16/2012WO2012075443A9 Methods for delivering clonidine compositions in a biodegradable polymer carrier and local steriods to a target tissue site
08/16/2012WO2012075379A3 Liquid viral formulations
08/16/2012WO2012075376A3 Lyophilized viral formulations
08/16/2012WO2012075081A3 High-strength testosterone undecanoate compositions
08/16/2012WO2012072977A3 Formulations comprising methylthionium chloride
08/16/2012WO2012071535A3 Pediatric formulation
08/16/2012WO2012065204A3 Vaginal suppository containing alum
08/16/2012WO2012061803A3 Compositions and methods for nanopolymer-based nucleic acid delivery
08/16/2012WO2012054447A3 Use of storage stable viscous phospholipid depot to treat wounds
08/16/2012WO2012044675A3 Emulsion method for preparing low residual solvent microparticles
08/16/2012WO2012040184A3 Novel low molecular weight cationic lipids for oligonucleotide delivery
08/16/2012WO2012039596A3 Pharmaceutical compositions for calanolides, their derivatives and analogues, and process for producing the same
08/16/2012WO2012037380A3 Formulations of guanylate cyclase c agonists and methods of use
08/16/2012WO2012031603A3 Airway administration of angiogenesis inhibitors
08/16/2012WO2012031164A3 Drug delivery by carbon nanotube arrays
08/16/2012WO2012028276A3 Device for metering an acid-containing composition
08/16/2012WO2012016703A3 Pharmaceutical dosage form comprising 6'-fluoro-(n-methyl- or n,n-dimethyl-)-4-phenyl-4',9'-dihydro-3'h-spiro[cyclohexane-1,1'-pyrano[3,4,b]indol]-4-amine
08/16/2012WO2012016699A3 Pharmaceutical dosage form comprising 6'-fluoro-(n-methyl- or n,n-dimethyl-)-4-phenyl-4,9'-dihydro-3'h-spiro[cyclohexane-1,1'-pyrano[3,4,b]indol]-4-amine
08/16/2012WO2012016698A3 Pharmaceutical dosage form comprising 6'-fluoro-(n-methyl- or n,n-dimethyl-)-4-phenyl-4',9'-dihydro-3'h-spiro[cyclohexane-1,1'-pyrano[3,4,b]indol]-4-amine for the treatment of neuropathic pain
08/16/2012WO2012016697A3 Pharmaceutical dosage form comprising 6'-fluoro-(n-methyl- or n,n-dimethyl-)-4-phenyl-4',9'-dihydro-3'h-spiro[cyclohexane-1,1'-pyrano[3,4,b]indol]-4-amine for the treatment of nociceptive pain
08/16/2012WO2012016695A3 Pharmaceutical dosage form comprising 6'-fluoro-(n-methyl- or n,n-dimethyl-)-4-phenyl-4',9'-dihydro-3'h-spiro[cyclohexane-1,1'-pyrano[3,4,b]indol]-4-amine
08/16/2012WO2012014052A4 Novel coated extended release pharmaceutical compositions containing paliperidone
08/16/2012WO2011154724A9 Injectable flowable composition comprising buprenorphine
08/16/2012WO2011139595A4 Elongated biodegradable depot for sustained drug release to treat chronic pelvic pain
08/16/2012WO2011134979A9 Stable aqueous mia/cd-rap formulations
08/16/2012US20120210451 Islet cell sheet, process for production thereof, and use thereof
08/16/2012US20120209223 Transdermal therapeutic system for administration of fentanyl or an analog thereof
08/16/2012US20120209056 Pad for herbal medicine in which release of medicinal ingredient can be controlled, and manufacturing method thereof
08/16/2012US20120209027 Method for Preparing Water-Soluble Polymer Derivatives Bearing a Terminal Carboxylic Acid
08/16/2012US20120208882 Organic Compounds
08/16/2012US20120208854 Therapeutic combination
08/16/2012US20120208754 Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicles
08/16/2012US20120207929 Dosage form exhibiting rapid disperse properties, methods of use and process for the manufacture of same
08/16/2012US20120207859 Calcium carbonate granulation
08/16/2012US20120207846 Selenium Nanoparticles with Improvded Biological Effects
08/16/2012US20120207845 Pharmaceutical composition of nanoparticles
08/16/2012US20120207843 Floating microgranules
08/16/2012US20120207842 Multiparticulate l-menthol formulations and related methods
08/16/2012US20120207841 Formulations of 6-mercaptopurine
08/16/2012US20120207840 Virion Derived Protein Nanoparticles For Delivering Diagnostic Or Therapeutic Agents For The Treatment Of Non-Melanoma Skin Cancer
08/16/2012US20120207839 Mineralized Collagen/Bioceramic Composite and Manufacturing Method Thereof
08/16/2012US20120207838 Treatment of Psoriasis Using Oral Dosage Forms of Nitrone Spin Traps
08/16/2012US20120207837 Bioerodible matrix for tissue involvement
08/16/2012US20120207836 Drug delivery systems (wafer) for pediatric use
08/16/2012US20120207834 Oral antimicrobial pharmaceutical compositions
08/16/2012US20120207833 Forms of rifaximin and uses thereof
08/16/2012US20120207832 Forms of rifaximin and uses thereof
08/16/2012US20120207831 Coated solid dosage forms
08/16/2012US20120207830 Calcium carbonate granulation
08/16/2012US20120207829 Calcium carbonate granulation
08/16/2012US20120207828 Large dose ribavirin formulations
08/16/2012US20120207827 Dimethyl sulfoxide (dmso) and methylsulfonylmethane (msm) formulations to treat osteoarthritis
08/16/2012US20120207826 Novel parasite therapy
08/16/2012US20120207825 Pharmaceutical compositions for reducing alcohol-induced dose dumping
08/16/2012US20120207824 Orally effective methylphenidate extended release powder and aqueous suspension product
08/16/2012US20120207823 Pharmaceutical pellets comprising modified starch and therapeutic applications therefor
08/16/2012US20120207822 Compositions and methods for treatment of cardiovascular disease
08/16/2012US20120207821 Liposomal formulation and use thereof
08/16/2012US20120207820 Composition for treatment of multiple sclerosis
08/16/2012US20120207819 Compositions and methods for wound healing
08/16/2012US20120207818 Composition for suppressing expression of target gene
08/16/2012US20120207817 Small interfering rnas and methods for prevention, inhibition and/or treatment of malignant progression of breast cancer
08/16/2012US20120207816 Transdermally Absorbable Donepezil-Containing Preparation
08/16/2012US20120207814 Aqueous patches containing diclofenac sodium
08/16/2012US20120207813 Rapidly acting dry sealant and methods for use and manufacture
08/16/2012US20120207812 Skincare compositions comprising salicyclic acid
08/16/2012US20120207811 Textile material for management of skin health complications associated with skin folds, and its method of use
08/16/2012US20120207810 Kinase Inhibitors
08/16/2012US20120207809 Method and system for effecting changes in pigmented tissue
08/16/2012US20120207808 Devices and methods for treating defects in the tissue of a living being
08/16/2012US20120207800 Compositions
1 ... 454 455 456 457 458 459 460 461 462 463 464 465 466 467 468 469 470 471 472 473 474 ... 2991